A carregar...
Identification of aggregates in therapeutic formulations of recombinant full‐length factor VIII products by sedimentation velocity analytical ultracentrifugation
ESSENTIALS: Factor VIII inhibitors are the most serious complication in patients with hemophilia A. Aggregates in biopharmaceutical products are an immunogenic risk factor. Aggregates were identified in recombinant full‐length factor VIII products. Aggregates in recombinant factor VIII products are...
Na minha lista:
| Publicado no: | J Thromb Haemost |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5809250/ https://ncbi.nlm.nih.gov/pubmed/29197156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.13917 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|